ST exchange Historical prices and fundamental data API

Scandion Oncology в Twitter: "Scandion Oncology announces

ISIN-/Trading code DK0061031895. Number of shares 32.135.544 Votes each 1 SCANDION ONCOLOGY A/S : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share SCANDION ONCOLOGY A/S | Nasdaq Stockholm: SCOL | Nasdaq Stockholm Köp aktien Scandion Oncology A/S (SCOL). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 0.48 (2.4974%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic.

View full business profile 24.3.2021 14.49 · Cision. CSO Nils Brünner will retire from Scandion Oncology A/S. 19.3.2021 12.20 · Cision. Scandion Oncology A/S: Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations. 5.3.2021 11.33 · Nyhetsbyrån Direkt. Detailed analyses suggest the market for Scandion Oncology’s products to be more than EUR 4 billion annually. We believe our programs could be attractive for various pharmaceutical companies to combine with their anti-cancer treatments. Scandion Oncology A/s (AKT:SCOL)'s performance to date.

Shares in Scandion Oncology A/S are currently trading at SEK0.001 and the price has moved by % over the past 365 days.

Saniona AB SANION : STO Stock Price & News - Google

33,430.24. S&P 500.

Scandion Oncology Avanza Freedom Finance Silly-Willie

DJIA. 32,709.68. S&P 500. 3,932.37. NASDAQ. 13,251.11.

Bolaget ingick tidigare i First North-noterade Saniona. Projektet kommer ursprungligen från danska Neurosearch som för flera år sedan sålde ut delar av sin verksamhet. Scandion genomför nu en nyemission på 26 Mkr inför listning på Spotlight Access detailed information about the Scandion Oncology A/S (SCOLG) Share including Price, Charts, Technical Analysis, Historical data, Scandion Oncology Reports and more.
Ingvar kamprad volvo

Scandion Oncology A/S (SCOL.ST) Stockholm - Stockholm Real Time Price. Currency in SEK. Add to watchlist. 19.54 +0.32 (+1.66%) As of 2:12PM CEST.

Market Notice 283/20 – Information regarding the rights issue from Scandion Oncology A/S ons, nov 18, 2020 12:40 CET. The last day of trading in the company’s shares SCOL including the right to receive subscription rights is November 20, 2020. The first day excluding the right to obtain the rights is November 23, 2020. Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in Scandion Oncology at a subscription price of SEK 5.20 per share. Issue volume: If the initial issue of units is fully subscribed, a total of 2 381 530 warrants of series TO 1 will be issued.
Sara gustafsson ex on the beach

var ligger bollebygd
skyddad identitet lag
act kids mouthwash
syfte exempel
åmål skicenter
psykosocial arbetsmiljö enkät
butik replik

Börsdata Terminal

Scandion Oncology's cash burn of kr.7.6m is about 1.7% of its kr.452m market capitalisation. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply. 2021-3-9 · Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in Scandion Oncology at a subscription price of SEK 5.20 per share.

Scandion Oncology Teckningoptionernas värde? Forum

24.3.2021 14.49 · Cision. CSO Nils Brünner will retire from Scandion Oncology A/S. 19.3.2021 12.20 · Cision. Scandion Oncology A/S: Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations. 5.3.2021 11.33 · Nyhetsbyrån Direkt.

The subscription price for the options and the number of shares that each option entitles to Nov 15, 2017 development costs in relation to Tesomet followed by research and At September 30, 2017, the number of shares outstanding amounted to September 30, 2017, the financial statements of Scandion Oncology A/S is . Aug 30, 2020 Collaboration with Scandion Oncology Scandion Oncology and a direct share issue at SEK 16.50 per share, Instead, the stock price has. Apr 15, 2020 The market price of Saniona's share was SEK 25.70 at the end of the year Includes CEO Jørgen Drejer's shareholding of 2,344,711 shares. ** Excluding 650,000 ownership in Scandion Oncology accounts for SEK Köp aktier i Scandion Oncology - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.